Nasdaq
RGC
Regencell Bioscience Holdings Limited
- Health Care
- Hong Kong
- Listed 2021
- 1 day
- −7.0%
- 1 month
- −8.2%
- 1 year
- −56.7%
$5.46 · Mkt cap $2.70B
At the 6 Aug 2026 close
Nasdaq
Regencell Bioscience Holdings Limited
$5.46 · Mkt cap $2.70B
At the 6 Aug 2026 close
Regencell Bioscience Holdings Limited trades under the ticker RGC on Nasdaq, in the Health Care sector ( Medicinal Chemicals and Botanical Products ). It has been listed since 2021. Its market capitalisation is $2.70B. The last closing price was $5.46, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −56.7%, and −8.2% over the past month. Returns are price returns and exclude dividends.
This page exists because RGC is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.